COMMUNIQUÉS West-GlobeNewswire

Guerbet : H1 2026 revenue.
23/07/2026
H1 2026 revenue H1 activity Revenue of €379.2m at 30 June 2026, nearly stable at CER 1 and on a like-for-like basis 2 (-0.1%) A 2.5% decline in Q2 at CER and on a like-for-like basis, marked by a solid recovery in the [...]
Guerbet : Chiffre d’affaires du 1er semestre 2026.
23/07/2026
Chiffre d’affaires du 1 er semestre 2026 Activité semestrielle Chiffre d’affaires au 30 juin 2026 de 379,2 M€, quasiment stable à TCC 1 et périmètre comparable 2 (-0,1%) Au deuxième trimestre, un repli de 2,5% à TCC et [...]
Invitation to Idorsia's HY 2026 Financial Reporting webcast and conference call
23/07/2026
Idorsia will publish its Half Year 2026 Financial Reporting on Thursday July 30, at 07:00 CEST. An investor webcast and conference call will be held to discuss the results on the same day. Date: Thursday, July 30, 2026 [...]
OKYO Pharma Announces Purchase of Shares by Director
23/07/2026
LONDON and NEW YORK, July 23, 2026 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (Nasdaq: OKYO ), a clinical-stage biopharmaceutical company developing investigational therapies for the treatment of neuropathic corneal pain ( [...]
Affidea accelerates its UK growth through strategic partnership with LIPS Healthcare
23/07/2026
LONDON, July 23, 2026 (GLOBE NEWSWIRE) -- Affidea, the pan-European provider of community-based clinics, advanced diagnostics, and specialist private healthcare services, today announces a strategic partnership with [...]
OPKO Health to Report Second Quarter 2026 Financial Results on July 27, 2026
23/07/2026
MIAMI, July 23, 2026 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (OPKO) (NASDAQ: OPK), a fully-integrated healthcare company focused on delivering next-generation solutions for serious diseases across established global [...]
First Choice Healthcare Solutions, Inc. Information on Share Consolidation
23/07/2026
MELBOURNE, Fla., July 23, 2026 (GLOBE NEWSWIRE) -- First Choice Healthcare Solutions, Inc., (OTC: FCHS), (“ First Choice ” or the “ Company ”), announced today that as previously approved by the Board of Directors of [...]
Atos achieves CMMC 2.0 Level 2 certification, strengthening readiness for mission-critical and complex defense programs
23/07/2026
Irving, Texas, USA – July 23, 2026 – Atos IT Solutions and Services Inc. has achieved Cybersecurity Maturity Model Certification (CMMC) 2.0 Level 2 for its North America Managed Detection & Response (MDR) Security [...]
Serotonin Centers Expands into Greater San Diego with New Del Mar Location
23/07/2026
Physician-Led Longevity Brand Brings Hormone Optimization, Medical Weight Loss, Peptide Therapy and Advanced Recovery Services to One of the Nation’s Most Health-Conscious Markets SAN DIEGO, July 23, 2026 (GLOBE [...]
YD Bio and EG BioMed Conclude Successful Exhibition at BIO Asia-Taiwan 2026, Highlighting Innovations in Ophthalmology, Oncology Diagnostics, and Clinical Services
23/07/2026
Taipei, Taiwan, July 23, 2026 (GLOBE NEWSWIRE) -- YD Bio Limited (“YD Bio” or the “Company”) (Nasdaq: YDES), a biotechnology company advancing DNA methylation-based cancer detection technology and ophthalmologic [...]
Atsena Therapeutics Receives Orphan Designation from the European Medicines Agency (EMA) for ATSN-101 and ATSN-201
23/07/2026
Orphan designation provides market exclusivity and development benefits in the European Union as both programs advance in global pivotal clinical trials DURHAM, N.C., July 23, 2026 (GLOBE NEWSWIRE) -- Atsena [...]
HCW Biologics Reaches Milestones for Its Proprietary Tetravalent Second-Generation T-Cell Engager Program On Track To Initiate Clinical Trials in First Half 2027
23/07/2026
Company requested Type B pre-IND meeting with U.S. FDA to discuss development and regulatory strategy for its investigational tetravalent T-cell engager, HCW11-018b HCW11-018b has demonstrated potential for treating [...]
PetMeds Announces Proposed Sale-Leaseback of Headquarters and Distribution Center Buildings for $37 Million
23/07/2026
DELRAY BEACH, Fla., July 23, 2026 (GLOBE NEWSWIRE) -- PetMed Express, Inc., dba PetMeds and parent company of PetCareRx (Nasdaq: PETS), today announced that it has entered into a definitive agreement for a sale- [...]
Collegium to Report Second Quarter 2026 Financial Results on August 6, 2026
23/07/2026
STOUGHTON, Mass., July 23, 2026 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a leading biopharmaceutical company focused on improving the lives of people living with serious and often misunderstood [...]
Curonix teams with AAOS to help address chronic pain with safer, patient-centered care solutions
23/07/2026
This support helps expand access to trusted clinical tools and patient resources designed to advance evidence-based pain management education POMPANO BEACH, Fla., July 23, 2026 (GLOBE NEWSWIRE) -- Curonix LLC, a leading [...]
Inhibikase Therapeutics Announces FDA Orphan Drug Designation Granted to IKT-001 for the Treatment of PAH
23/07/2026
WILMINGTON, Del., July 23, 2026 (GLOBE NEWSWIRE) -- Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (“Inhibikase” or “Company”), a clinical-stage pharmaceutical company developing IKT-001 for Pulmonary Arterial Hypertension [...]
Bone Biologics Issues Mid-Year Shareholder Update Highlighting Progress Across 2026 Priorities
23/07/2026
Strengthened capital position supports continued advancement of NB1 clinical development, manufacturing readiness and intellectual property initiatives through Q2 2027 BURLINGTON, Mass, July 23, 2026 (GLOBE NEWSWIRE [...]
iMDx GraftAssure Assay Guides Use of Potentially Kidney-Graft-Saving Drug in New Lancet Group Publication
23/07/2026
Study published by Lancet Regional Health helps doctors manage new class of drugs for kidney transplant patients suffering organ rejection Serial monitoring of patients through donor-derived cell-free DNA (dd-cfDNA) [...]
Apyx Medical Corporation to Release Second Quarter of Fiscal Year 2026 Financial Results on August 6, 2026
23/07/2026
CLEARWATER, Fla., July 23, 2026 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (NASDAQ:APYX) (the “Company” or “Apyx Medical”), the leader in surgical aesthetics marketed and sold as Renuvion ® and the AYON Body [...]

Pages